A phase 3 double blind RCT shows a strong positive trend towards a novel diagnostic TB test positivity with increasing risk of infection, garanteeing the same safety profile of the Mantoux TST. The new test (called C-tb) is unaffected by BCG vaccination status which might  provide more accurate treatment guidance in vaccinated patients.

Source: TheLancet.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s